Gelspheres Embolic Agent
Device, Neurovascular Embolization. 510(k) K023089, from Biocure, Inc. (South West Ranches, FL). Product code HCG, class 2.
As of Nov 19, 2026, K023089 is an FDA 510(k) held by Biocure, Inc., substantially equivalent on Dec 16, 2002 after 90 days, with no recalls tied to it in FDA's recall database.
- Review time: 90 days
- Recalls: 0
- Cited as a predicate by: 2 devices
"GelSpheres™ Embolic Agent is intended for embolization of hypervascular tumors and arteriovenous malformations."
- Gelspheres Microspheres and Bead Block Compressible MicrospheresK042231 · Biocompatibles UK Limited · Nov 12, 2004
- Gelspheres / Beadblock Compressible MicrospheresK033761 · Biocompatibles UK Limited · Feb 4, 2004
- Micrusframe (MFR100202); Micrusframe (MFR100253); Micrusframe (MFR100305); Micrusframe (MFR100356); Micrusframe…K262419 · Cerenovus, Inc. · Aug 14, 2026
- Target Xtra Detachable CoilK261772 · Stryker Neurovscular · Jun 24, 2026
- Numen™ Helia Coil Embolization System; NumenFR™ Detachment SystemK260351 · MicroPort NeuroTech (Shanghai) Co., Ltd. · May 20, 2026
- Optima Coil System (OptiOne Coil System)K254221 · Balt USA, LLC · Jan 27, 2026
- Target Detachable CoilK252694 · Stryker Neurovascular · Dec 11, 2025
- InZone IST Detachment System; IZDS Connecting CableK251832 · Stryker Neurovascular · Oct 17, 2025
- Optima Coil System (Optima Packing Coil System)K252700 · Balt USA, LLC · Sep 26, 2025
- Numen™ Coil Embolization System; NumenFR™ Detachment SystemK242154 · MicroPort NeuroTech (Shanghai) Co., Ltd. · Sep 30, 2024
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Sep 17, 2002
- Review panel
- Neurology
- Regulation
- 21 CFR 882.5950
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files